GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
3,231
Funds Holding Change
+18
Funds Holding Growth
+0.6%
Value
$590B
Holding in Top 10
487
Top 10 Change
-195
Top 10 Growth
-29%
Value Growth
-0.6%
New
166
Increased
1,358
Reduced
1,495
Closed
104
Capital Inflow
$17.5B
Capital Outflow
$25.3B
Net Capital Flow
-$7.82B
Capital Flow Change
-$10.5B
Calls
$6.17B
Puts
$6.78B
Net Calls
-$612M
Put/Call Ratio
1.1